Combined Assessment of Serum Alpha-Synuclein and Rab35 is a Better Biomarker for Parkinson's Disease

BACKGROUND AND PURPOSE: It is essential to develop a reliable predictive serum biomarker for Parkinson's disease (PD). The accumulation of alpha-synuclein (αSyn) and up-regulated expression of Rab35 participate in the etiology of PD. The purpose of this investigation was to determine whether th...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Neurol
Autori principali: Wang, Hung-Li, Lu, Chin-Song, Yeh, Tu-Hsueh, Shen, Yu-Ming, Weng, Yi-Hsin, Huang, Ying-Zu, Chen, Rou-Shayn, Liu, Yu-Chuan, Cheng, Yi-Chuan, Chang, Hsiu-Chen, Chen, Ying-Ling, Chen, Yu-Jie, Lin, Yan-Wei, Hsu, Chia-Chen, Lin, Huang-Li, Chiu, Chi-Han, Chiu, Ching-Chi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Neurological Association 2019
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6785464/
https://ncbi.nlm.nih.gov/pubmed/31591837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3988/jcn.2019.15.4.488
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi